(S1 (S (S (NP (NP (NNS Effects)) (PP (IN of) (NP (NN doxycycline))) (PP (IN on) (NP (NP (ADJP (FW in) (FW vitro)) (NP (NP (NN growth)) (, ,) (NP (NN migration)) (, ,) (CC and) (NP (NN gelatinase))) (NN activity)) (PP (IN of) (NP (NN breast) (NN carcinoma) (NNS cells))))))) (. .)))
(S1 (S (S (NP (JJ Metastatic) (NN disease)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ major) (NNS causes)) (PP (IN of) (NP (NP (NN death)) (PP (IN from) (NP (NN cancer))) (PP (IN in) (NP (JJ human) (NNS beings)))))))))) (. .)))
(S1 (S (S (S (NP (JJ Several) (NN enzyme) (NNS systems)) (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (DT the) (JJ metastatic) (NN process))))))) (, ,) (CC but) (S (NP (NP (DT the) (NNS metalloproteinases)) (PRN (-LRB- -LRB-) (NP (NN MPs)) (-RRB- -RRB-))) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (JJ major) (NN group)) (VP (VBN involved) (PP (IN in) (NP (NP (JJ most) (NNS instances)) (PP (IN of) (NP (JJ neoplastic) (NN invasion))))))))))))) (. .)))
(S1 (S (S (NP (VBN Increased) (NN MP) (NN activity)) (VP (VBZ has) (VP (VBN been) (VP (VBN correlated) (PP (IN with) (NP (NP (DT the) (JJ metastatic) (NN potential)) (PP (IN of) (NP (NP (JJ many) (NNS cancers)) (, ,) (PP (VBG including) (NP (NN breast) (NN cancer))))))))))) (. .)))
(S1 (S (S (NP (NNS MPs)) (ADVP (RB also)) (VP (VBP play) (NP (DT a) (NN role)) (PP (IN in) (NP (NN tumor) (NN angiogenesis))))) (. .)))
(S1 (S (S (NP (NNS Tetracyclines)) (VP (VBP are) (NP (NP (JJ antimicrobial) (NNS agents)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB suppress) (NP (NN MP) (NN activity)) (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NNS tissues)) (, ,) (PP (VBG including) (NP (NP (NN gingiva)) (, ,) (NP (NN bone)) (, ,) (CC and) (NP (NN cartilage))))))))))))))) (. .)))
(S1 (S (S (NP (JJ Several) (NNS reports)) (VP (VBP have) (VP (VBN indicated) (SBAR (IN that) (S (NP (NNS tetracyclines)) (VP (MD can) (VP (VB suppress) (NP (NN tumor) (NN MPs)) (PP (IN as) (NP (NN well)))))))))) (. .)))
(S1 (S (S (NP (NP (DT A) (JJ synthetic) (NN tetracycline)) (, ,) (NP (NN doxycycline)) (, ,)) (VP (VBZ inhibits) (NP (NP (NN migration)) (PP (IN of) (NP (JJ human) (NN MDA-MB-435) (NN breast) (NN adenocarcinoma) (NNS cells)))) (PP (IN through) (NP (NP (DT a) (VBN reconstituted) (NN basement) (NN membrane) (-LRB- -LRB-) (NN Matrigel) (-RRB- -RRB-)) (, ,) (NP (NP (DT an) (NN assay)) (VP (VBN used) (PP (IN as) (NP (NP (DT an) (ADJP (FW in) (FW vitro)) (NN surrogate)) (PP (IN for) (NP (NP (DT the) (ADJP (FW in) (FW vivo)) (NN process)) (PP (IN of) (NP (NP (NN tumor) (NN invasion)) (PP (IN through) (NP (NN basement) (NNS membranes))))))))))))))) (. .)))
(S1 (S (S (ADVP (RB Additionally)) (, ,) (NP (NN doxycycline)) (VP (VP (VBZ diminishes) (NP (NP (DT the) (NN proliferation)) (PP (IN of) (NP (DT this) (NN breast) (NN cancer) (NN cell) (NN line))))) (CC and) (ADVP (RB also)) (VP (VBZ decreases) (NP (PRP$ its) (JJ gelatinolytic) (NN activity)) (, ,) (SBAR (IN as) (S (VP (VBN determined) (PP (IN by) (NP (NN gel) (NN zymography))))))))) (. .)))
